Ensign Peak Advisors
ESPR

Ensign Peak Advisors’s Esperion Therapeutics ESPR Stock Holding History

Ensign Peak Advisors’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-133,150
Closed -$666K – 2220
2021
Q4 		$666K Buy
+133,150
New +$1.07M ﹤0.01% 1491
2020
Q4 		– Sell
-21,855
Closed -$812K – 1866
2020
Q3 		$812K Sell
21,855
-3,590
-14% -$142K ﹤0.01% 1397
2020
Q2 		$1.31M Sell
25,445
-3,320
-12% -$139K ﹤0.01% 1179
2020
Q1 		$908K Sell
28,765
-7,187
-20% -$379K ﹤0.01% 1205
2019
Q4 		$2.14M Buy
+35,952
New +$1.62M 0.01% 1028

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return